BWF Announces the 2009 Clinical Scientist Awards in Translational Research

19 May 2009

The Burroughs Wellcome Fund has announced four investigators as the 2009 recipients of its Clinical Scientist Awards in Translational Research.

The awards, which provide $150,000 per year over five years ($750,000), are intended to support established, independent physician-scientists who are dedicated to translational research—the two-way transfer between laboratory research and patient treatment.  Researchers must also be committed to mentoring physician-scientist trainees.

The award provides the freedom and flexibility to explore scientific questions, apply the resulting knowledge at the bedside, and bring insights from the clinical setting back to the laboratory for further study.

Candidates must have an M.D. or M.D.-Ph.D. degree and hold an appointment or joint appointment in a subspecialty of clinical medicine. They must also be citizens or permanent residents of the U.S. and Canada and hold a current license to practice medicine in the U.S. or Canada.

"The recipients of the Clinical Scientist Award excel not only in research, but also in mentoring the next generation of clinical scientists," said BWF President Dr. John Burris.  "By making mentoring a priority, we hope to contribute to the future pipeline of clinicians conducting research."

Since the award’s inception in 1997, BWF has made a total of 97 awards, which is an investment of nearly $73 million in the careers of translational researchers.

Following are the 2009 award recipients, along with their institutions and project titles:

Thomas R. Hawn, M.D., Ph.D.
University of Washington
Variation and regulation of innate immunity to Mycobacteria

Robert O. Heuckeroth, M.D., Ph.D.
Washington University
Genetic and non-genetic risk for Hirschsprung disease

Ari Melnick, M.D.
Weill Medical College of Cornell University
Differentiation therapy for B-cell lymphomas

Stephanie Ware, M.D., Ph.D.
University of Cincinnati
Uncovering novel genetic causes and risks in congenital heart disease patients


For more information:
Russ Campbell, Communications Officer
Telephone: (919) 991-5119